Abstract
Sibutramine HCl, a monoamine reuptake inhibitor type of antidepressant, was administered to healthy male volunteers as either a single dose (12.5 or 50 mg) or repeated treatment (5–20 mg once daily or 15 mg twice daily). Plasma, obtained at regular intervals during and after sibutramine HCl or placebo treatment, was assayed in vitro for its ability to inhibit the uptake of [3H]-noradrenaline (NA) by rat cortical synaptosomes, [3H]-5-hydroxytryptamine (5HT) by human platelets and [14C]-dopamine (DA) by rat striatal synaptosomes. After both single and repeated sibutramine HCl administration, the rank order of uptake inhibition was [3H]-NA>[3H]-5HT>[14C]-DA. The level of monoamine uptake inhibition increased on daily administration to a plateau 4–6 days after initiation of treatment, for example, approximately 60% and 40% inhibition of [3H]-NA and [3H]-5HT, respectively, following 15 mg sibutramine HCl twice daily. The pattern of monoamine uptake inhibition following sibutramine HCl administration to man is similar to that observed in sibutramine HCl-treated rats, and probably at least partly reflects inhibition of uptake by drug metabolites in both species. The inhibition of monoamine uptake following sibutramine HCl administration to man is consistent with an antidepressant effect.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Åberg-Wistedt A, Jostell K-G, Ross SB, Westerlund D (1981) Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression. Psychopharmacology 74:297–305
Armitage P (1971) Statistical methods in medical research. Blackwell, Oxford
Åsberg M, Ringberger V-A, Sjöqvist F, Thorén P, Träskman L, Tuck JR (1977) Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine. Clin Pharmacol Ther 21:201–207
Banerjee SP, Kung LS, Riggi SJ, Chanda SK (1977) Development of β-adrenergic receptor subsensitivity by antidepressants. Nature 268:455–456
Bertilsson L, Tuck JR, Siwers B (1980) Biochemical effects of zimelidine in man. Eur J Clin Pharmacol 18:483–487
Buckett WR, Luscombe GP, Thomas PC (1988a) BTS 54 524 an approach to a rapidly acting antidepressant. In: Briley M, Fillion G (eds) New concepts in depression. Macmillan, London, pp 167–172
Buckett WR, Thomas PC, Luscombe GP (1988b) The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antide-pressant which induces rapid noradrenergic down-regulation. Prog Neuropsychopharmacol Biol Psychiatry 12:575–584
Heal DJ, Butler SA, Hurst EM, Buckett WR (1989) Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease β1-but not β2-adrenoceptors in rat cortex. J Neurochem 53:1019–1025
Hyttel J (1982) Citalopram — pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 6:277–295
Lingjaerde O (1984) Platelet serotonin uptake inhibition as a basis for monitoring antidepressant drug treatment. J Clin Psychopharmacol 4:76–81
Luscombe GP, Hopcroft RH, Thomas PC, Buckett WR (1989) The contribution of metabolites to the rapid and potent down-regulation of rat cortical β-adrenoceptors by the putative antidepressant sibutramine hydrochloride. Neuropharmacology 28:129–134
Nyström C, Ross SB, Hällström T, Kelder D (1986) Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed patients. Acta Psychiatr Scand 73:133–138
Peroutka SJ, Snyder SH (1980) Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210:88–90
Richelson E, Pfenning M (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104:277–286
Ross SB, Åberg-Wistedt A (1983) Inhibitors of serotonin and noradrenaline uptake in human plasma after withdrawal of zimelidine and clomipramine treatment. Psychopharmacology 79:298–303
Ross SB, Renyi AL (1975) Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of3H-noradrenaline and14C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain. Acta Pharmacol Toxicol 36:382–394
Ross SB, Renyi AL (1977) Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)-and (E)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl)allylamines and their secondary analogues. Neuropharmacology 16:57–63
Siwers B, Ringberger V-A, Tuck JR, Sjöqvist F (1977) Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients. Clin Pharmacol Ther 21:194–200
Träskman L, Åsberg M, Bertilsson L, Cronholm B, Mellström B, Neckers LM, Sjöqvist F, Thorén P, Tybring G (1979) Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression. Clin Pharmacol Ther 26:600–610
Tuck JR, Punell G (1973) Uptake of [3H]5-hydroxytryptamine and [3H]noradrenaline by slices of rat brain incubated in plasma from patients treated with chlorimipramine, imipramine or amitriptyline. J Pharm Pharmacol 25:573–574
Tuomisto J, Tukiainen E, Voutilainen R, Tuomainen P (1980) Inhibition of 5-hydroxytryptamine and noradrenaline uptake in platelets and synaptosomes incubated in plasma from human subjects treated with amitriptyline or nortriptyline: utilization of the principle for a bioassay method. Psychopharmacology 69:137–142
Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw-Hill, New York
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Luscombe, G.P., Slater, N.A., Lyons, M.B. et al. Effect on radiolabelled-monoamine uptake in vitro of plasma taken from healthy volunteers administered the antidepressant sibutramine HCl. Psychopharmacology 100, 345–349 (1990). https://doi.org/10.1007/BF02244604
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244604